Back to Rheumatology
-
Allergy & Clinical Immunology -
Cardiovascular Medicine -
Gastroenterology & Hepatology -
General Medicine -
Genetic Medicine -
Geriatric & Palliative Medicine -
Hematology & Oncology -
Hospital Medicine -
Infectious Diseases -
Metabolism, Endocrinology & Diabetes -
Nephrology -
Pulmonary & Critical Care Medicine -
Rheumatology
Innovative research conducted by our faculty and staff have paved the way for more effective methods of prevention, diagnosis and treatment of rheumatic diseases.
Research interests of our faculty represent a broad base of expertise in basic and clinical sciences in rheumatic diseases including rheumatoid arthritis, lupus, antiphospholipid syndrome, scleroderma, myositis, vascular disease, spondyloarthropathies, gout and autoimmune eye diseases.
T32 Training Program
Our T32 Scientist Training in Rheumatology Research Program is designed to provide trainees with the tools needed to become successful independent investigators focused on improving the understanding of, and care for, people living with rheumatic diseases.
Research Centers & Programs
Department News
Nine faculty members from the Department of Internal Medicine named to Clarivate’s Highly Cited Researchers 2024 List.
Department News
On Wednesday, October 30, 2024, a ribbon-cutting ceremony was held to celebrate and officially mark the opening of the new Translational Immunology Research lab space at the North Campus Research Complex.
Health Lab
Using the Ab38 antibody to target the CD38 enzyme could be a new gateway to treat and prevent fibrosis for patients with systemic sclerosis.
Health Lab
Targeting and blocking the sCD13 protein from interacting with the B1R protein can pave the way for new fibrosis and systemic sclerosis treatments.
Health Lab
A research team is investigating how metabolism – the process by which cells turn sugars, fats and proteins into energy – is used to make NETs in regards to antiphospholipid syndrome.
Research News
Dr. Yu (Ray) Zuo recently sat down with podcast host, Victoria Shanmugam, MBBS, MRCP, CCD, to discuss whether calprotectin can be a functional biomarker for those with APS thrombocytopenia and what the future holds for this study’s conclusions.
